Log in

AMP Armephaco Joint Stock Co UPCOM · Vietnam

Armephaco Joint Stock Co (AMP) news

Armephaco Joint Stock Co is a public biotech or pharmaceutical company listed on UPCOM under the ticker AMP, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Armephaco Joint Stock Co news

We have not published a story on Armephaco Joint Stock Co yet. When there is news, it will appear here.

Questions about Armephaco Joint Stock Co

What is the ticker symbol of Armephaco Joint Stock Co?

Armephaco Joint Stock Co trades under the ticker AMP on UPCOM.

Where is Armephaco Joint Stock Co listed?

Armephaco Joint Stock Co is listed on UPCOM.

Which country or territory is Armephaco Joint Stock Co listed under?

Our directory records Armephaco Joint Stock Co under Vietnam.

What does Armephaco Joint Stock Co do?

Our directory classifies Armephaco Joint Stock Co as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Armephaco Joint Stock Co?

The ISIN recorded for Armephaco Joint Stock Co is VN000000AMP7.

Does aibio.space cover Armephaco Joint Stock Co?

aibio.space lists Armephaco Joint Stock Co among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Armephaco Joint Stock Co?

Companies in our directory listed in the same country and business area as Armephaco Joint Stock Co: Ben Tre Pharmaceutical JSC, Mekophar Chemical Pharmaceutical Joint Stock, OPC Pharmaceutical Joint Stock, HaTinh Pharmaceutical Joint Stock Co, Nova Consumer Group Joint Stock, Ha Tay Pharmaceutical JSC.

Investor discussion: Armephaco Joint Stock Co

Members talk about Armephaco Joint Stock Co (AMP). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Armephaco Joint Stock Co is a public biotech or pharmaceutical company listed on UPCOM under the ticker AMP, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Armephaco Joint Stock Co
Ticker
AMP
Listing
UPCOM
Country or territory
Vietnam
Business scope
Pharmaceuticals: Major
ISIN
VN000000AMP7
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.